Effect of Adjuvant Chemotherapy after Radical Resection on Colon Cancer Prognosis and Its Relative Factors Analysis in Elderly Patients

秦琼,杨林,孙永琨,应建明,宋岩,张雯,王金万,周爱萍

DOI: https://doi.org/10.3760/cma.j.issn.0254-9026.2016.03.018

2016-01-01

Abstract:Objective To explore the effect of adjuvant chemotherapy on colon cancer prognosis and its prognostic factors in elderly patients with stage Ⅱ / Ⅲ colon cancer after radical resection.Methods The clinical and pathological as well as postoperative therapy data were collected and analyzed in elderly patients (aged ＞ 60 years) with stage Ⅱ/Ⅲ colon cancer undergoing radical resection.The disease-free survival (DFS) and overall survival (OS) rate was compared between the surgery-alone group and the postoperative adjuvant chemotherapy group by Kaplan-Meier analysis,and patients were sub-grouped based on clinical stage.The analysis of prognostic factors was conducted by Cox regression.Results Among 317 patients,113 patients received surgery alone and 204 patients received postoperative adjuvant chemotherapy (fluorouracil alone or combined with oxaliplatin).There were no significant differences in DFS and OS between the two groups (69.0％ vs.69.6％,69.9％ vs.76.0％,P=0.966 and 0.250).No difference in DFS and OS in patients with stage Ⅱ colon cancer was observed between the two groups (82.3％ vs.82.1％,83.5％ vs.88.4％,P=0.959 and 0.306).However,postoperative adjuvant chemotherapy improved DFS and OS in patients with stage Ⅲ colon cancer (38.2％ vs.58.7％,38.2％ vs.65.1％,P=0.02 and 0.003).Multivariate analysis showed that the independent predictors for prognosis were T4,N +,combination with vascular invasion,surgery alone,preoperative CA19-9 level.Conclusions Postoperative adjuvant chemotherapy cannot improve the DFS and OS in elderly patients with stage Ⅱ colon cancer,but can improve the overall survival rate in those with stage Ⅲ.TNM staging,vascular invasion,preoperative CA19-9 level and the therapeutic model after surgery are the independent factors influencing the prognosis in elderly patients with colon cancer.